Illumina | ILMN - Operating Expenses

Stock Price
118.94
Daily Change
3.38 2.92%
Monthly
2.09%
Yearly
38.95%
Q1 Forecast
115.35

Illumina reported $903M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 423M 1.06B Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 229M 3.4M Sep/2025
OraSure Technologies USD 23.07M 4.36M Sep/2024
Pacific Biosciences Of California USD 74.08M 107.7M Sep/2024
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Standard Biotools USD 43.02M 2.44M Sep/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Waters USD 661.85M 1.67B Dec/2025